What happened
Alex Scott and colleagues at the University of Cape Town Lung Institute and the South African Medical Research Council reviewed computer-aided detection of TB in Africa. They sought studies of active case finding published from January 2012 to February 2023 that tested the software against sputum culture or nucleic acid tests. Five studies from Kenya, South Africa and Zambia qualified, with 101,060 participants and 834 people with TB. All used CAD4TB, and one also tested qXR. Pooled sensitivity was 0.87 and specificity 0.74, just below WHO's target of at least 0.90 and 0.70 for a screening test. At 1% prevalence, 9 of every 10 people with TB would be flagged, and 257 of 990 without TB would be sent for testing. The authors found a high risk of bias in all five studies, and three set their thresholds after analysis. The review appeared in Open Forum Infectious Diseases on 17 January 2024.
Sources
-
Peer-reviewed study, by authors with no tie to the system.
Scott, A. J., T. Perumal, A. Hohlfeld, et al. Diagnostic Accuracy of Computer-Aided Detection During Active Case Finding for Pulmonary Tuberculosis in Africa: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases 11(2): ofae020, 2024 (published online 17 January 2024).
A meta-analysis revealed pooled sensitivity of 0.87 (95% CI, 0.78-0.96) and specificity of 0.74 (95% CI, 0.55-0.93), just below the World Health Organization (WHO)-recommended target product profile
We found a high risk of bias and applicability concerns across all studies.
Details
AI system
- Reported configuration
-
CAD4TB v5, v6 and v7; qXR v3
- Workflow
-
The software scored each chest X-ray for abnormalities that suggest TB, against a threshold. Sputum culture or nucleic acid tests served as the reference standard.
Follow-up
- Conditions for replication
-
The threshold suits the setting, since a more sensitive threshold raises the number of confirmatory tests. Participants are 15 years or older.
Entry details
- Sector
-
Healthcare (tuberculosis screening).
- Purpose
-
Delft Imaging and Qure.ai built CAD4TB and qXR to read chest X-rays and score abnormalities that suggest tuberculosis.
References
- Other identifiers
-
Prospero: CRD42022364968.
Not yet checked: model, provider, role, configuration, inputs and outputs, autonomy, human oversight, AI contribution, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, category mappings.
Cite this record
Peter H. Vartanian. (2026). CAD4TB falls just short of WHO's bar for TB screening in Africa (AIBD-0915). Artificial Intelligence Benefits Database, edition of 31 October 2026. https://petervartanian.xyz/aibd/records/AIBD-0915.html (archived at https://doi.org/10.7910/DVN/AADSII, version 4.0)